Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXM6OK
|
||||
| Drug Name |
6-{1-[2-(Quinolin-5-yloxy)-ethyl]-pyrrolidin-3-ylmethoxy}-4H-benzo[1,4]oxazin-3-one
|
||||
| Synonyms |
CHEMBL183034
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H25N3O4
|
||||
| Canonical SMILES |
O=C1COc2ccc(OCC3CCN(CCOc4cccc5ncccc45)C3)cc2N1
|
||||
| InChI |
InChI=1S/C24H25N3O4/c28-24-16-31-23-7-6-18(13-21(23)26-24)30-15-17-8-10-27(14-17)11-12-29-22-5-1-4-20-19(22)3-2-9-25-20/h1-7,9,13,17H,8,10-12,14-16H2,(H,26,28)
|
||||
| InChIKey |
YYHMHYNXVHTUCR-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.